Literature DB >> 20971673

Genetic variation of the mitochondrial complex I subunit NDUFV2 and Parkinson's disease.

Kenya Nishioka1, Carles Vilariño-Güell, Stephanie A Cobb, Jennifer M Kachergus, Owen A Ross, Emna Hentati, Faycal Hentati, Matthew J Farrer.   

Abstract

NADH dehydrogenase ubiquinone flavoprotein 2 (NDUFV2), encoding a subunit of mitochondrial complex I, is a candidate gene for several neuronal diseases; schizophrenia, bipolar disorder and Parkinson disease (PD). We screened the entire coding region of NDUFV2 in 33 familial PD patients of North African Arab-Berber ethnicity in which all known genetic forms of PD had been excluded. We detected one novel substitution p.K209R (c.626A>G) in one PD proband. Segregation analysis within the family is inconclusive due to small sample size, but consistent with an autosomal dominant mode of inheritance. Subsequent screening of this mutation in ethnically matched sporadic PD patients (n = 238) and controls (n = 371) identified p.K209R in one additional patient. The clinical features of the mutation carriers revealed a mild form of parkinsonism with a prognosis similar to idiopathic PD. Our findings suggest further studies addressing the role of NDUFV2 variation in PD may be warranted.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971673      PMCID: PMC4381965          DOI: 10.1016/j.parkreldis.2010.09.007

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  13 in total

1.  Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families.

Authors:  Lianna Ishihara; Rachel A Gibson; Liling Warren; Rim Amouri; Kelly Lyons; Catherine Wielinski; Christine Hunter; Jina E Swartz; Ramu Elango; P Anthony Akkari; David Leppert; Linda Surh; Kevin H Reeves; Siwan Thomas; Leigh Ragone; Nobutaka Hattori; Rajesh Pahwa; Joseph Jankovic; Martha Nance; Alan Freeman; Neziha Gouider-Khouja; Mounir Kefi; Mourad Zouari; Samia Ben Sassi; Samia Ben Yahmed; Ghada El Euch-Fayeche; Lefkos Middleton; David J Burn; Ray L Watts; Faycal Hentati
Journal:  Mov Disord       Date:  2007-01       Impact factor: 10.338

2.  Complex I polymorphisms, bigenomic heterogeneity, and family history in Virginians with Parkinson's disease.

Authors:  Russell H Swerdlow; Bradley Weaver; Amy Grawey; Connie Wenger; Eric Freed; Bradford B Worrall
Journal:  J Neurol Sci       Date:  2006-06-19       Impact factor: 3.181

3.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

4.  Genotype in the 24-kDa subunit gene (NDUFV2) of mitochondrial complex I and susceptibility to Parkinson disease.

Authors:  N Hattori; H Yoshino; M Tanaka; H Suzuki; Y Mizuno
Journal:  Genomics       Date:  1998-04-01       Impact factor: 5.736

5.  What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study.

Authors:  A J Hughes; Y Ben-Shlomo; S E Daniel; A J Lees
Journal:  Neurology       Date:  1992-06       Impact factor: 9.910

6.  Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson's disease.

Authors:  Ikuko Mizuta; Tatsuhiko Tsunoda; Wataru Satake; Yuko Nakabayashi; Masahiko Watanabe; Atsushi Takeda; Kazuko Hasegawa; Kenji Nakashima; Mitsutoshi Yamamoto; Nobutaka Hattori; Miho Murata; Tatsushi Toda
Journal:  Hum Genet       Date:  2008-06-22       Impact factor: 4.132

7.  PINK1 mutations and parkinsonism.

Authors:  L Ishihara-Paul; M M Hulihan; J Kachergus; R Upmanyu; L Warren; R Amouri; R Elango; R K Prinjha; A Soto; M Kefi; M Zouari; S B Sassi; S B Yahmed; G El Euch-Fayeche; P M Matthews; L T Middleton; R A Gibson; F Hentati; M J Farrer
Journal:  Neurology       Date:  2008-08-06       Impact factor: 9.910

8.  Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder.

Authors:  Shinsuke Washizuka; Chihiro Kakiuchi; Kanako Mori; Hiroshi Kunugi; Osamu Tajima; Tsuyoshi Akiyama; Shinichiro Nanko; Tadafumi Kato
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-07-01       Impact factor: 3.568

Review 9.  Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.

Authors:  Claire Henchcliffe; M Flint Beal
Journal:  Nat Clin Pract Neurol       Date:  2008-11

10.  A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease.

Authors:  Kenya Nishioka; Mounir Kefi; Barbara Jasinska-Myga; Christian Wider; Carles Vilariño-Güell; Owen A Ross; Michael G Heckman; Lefkos T Middleton; Lianna Ishihara-Paul; Rachel A Gibson; Rim Amouri; Samia Ben Yahmed; Samia Ben Sassi; Mourad Zouari; Ghada El Euch; Matthew J Farrer; Faycal Hentati
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-09-02       Impact factor: 10.154

View more
  18 in total

1.  Whole genome expression profile in neuroblastoma cells exposed to 1-methyl-4-phenylpyridine.

Authors:  E Mazzio; K F A Soliman
Journal:  Neurotoxicology       Date:  2012-07-07       Impact factor: 4.294

2.  Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.

Authors:  Abby L Olsen; Mel B Feany
Journal:  Glia       Date:  2019-07-03       Impact factor: 7.452

Review 3.  Mitochondria: the next (neurode)generation.

Authors:  Eric A Schon; Serge Przedborski
Journal:  Neuron       Date:  2011-06-23       Impact factor: 17.173

4.  PARK2 variability in Polish Parkinson's disease patients--interaction with mitochondrial haplogroups.

Authors:  Katarzyna Gaweda-Walerych; Krzysztof Safranow; Barbara Jasinska-Myga; Monika Bialecka; Gabriela Klodowska-Duda; Monika Rudzinska; Krzysztof Czyzewski; Stephanie A Cobb; Jaroslaw Slawek; Maria Styczynska; Grzegorz Opala; Marek Drozdzik; Kenya Nishioka; Matthew J Farrer; Owen A Ross; Zbigniew K Wszolek; Maria Barcikowska; Cezary Zekanowski
Journal:  Parkinsonism Relat Disord       Date:  2012-02-22       Impact factor: 4.891

5.  The Effect of Aging on Mitochondrial Complex I and the Extent of Oxidative Stress in the Rat Brain Cortex.

Authors:  Zuzana Tatarkova; Maria Kovalska; Veronika Timkova; Peter Racay; Jan Lehotsky; Peter Kaplan
Journal:  Neurochem Res       Date:  2016-05-09       Impact factor: 3.996

Review 6.  The two-century journey of Parkinson disease research.

Authors:  Serge Przedborski
Journal:  Nat Rev Neurosci       Date:  2017-03-17       Impact factor: 34.870

Review 7.  POLG1-related and other "mitochondrial Parkinsonisms": an overview.

Authors:  Daniele Orsucci; Elena Caldarazzo Ienco; Michelangelo Mancuso; Gabriele Siciliano
Journal:  J Mol Neurosci       Date:  2011-01-08       Impact factor: 3.444

8.  Genome-wide association for sensitivity to chronic oxidative stress in Drosophila melanogaster.

Authors:  Katherine W Jordan; Kyle L Craver; Michael M Magwire; Carmen E Cubilla; Trudy F C Mackay; Robert R H Anholt
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

Review 9.  The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease.

Authors:  Elizabeth A Mazzio; Fran Close; Karam F A Soliman
Journal:  Int J Mol Sci       Date:  2011-01-17       Impact factor: 5.923

10.  Chronic phencyclidine increases synapsin-1 and synaptic adaptation proteins in the medial prefrontal cortex.

Authors:  Chris Pickering; Mia Ericson; Bo Söderpalm
Journal:  ISRN Psychiatry       Date:  2013-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.